You may be wondering why a pharmaceutical company would attend a cutting edge technology and digital festival like SXSW Interactive, which brings together the brightest minds in emerging technology. It’s simple: here at GSK, innovation (PDF) is our business. For the past 150 years, we’ve been developing innovative medicines, vaccines and consumer healthcare products that are used by millions of people around the world.
And we aren’t slowing down. We continue to look at new ways to innovate in the healthcare space. In fact last year at SXSW 2015, we presented our work on biosensors in partnership with McLaren. And this year for SXSW 2016, we’re presenting our work on bioelectronic medicine in a session called Inner Space: Bioelectronics and Medicine's Future.
You may also like
Working towards the development of bioelectronic medicines
Our Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.
Harnessing the electrical language of the body to treat disease
Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.